There is a very high mortality rate associated with this complication, but prognostic selleck compound factors associated with NOMI are not well-known. Method. In this study, we retrospectively reviewed the records of dialysis patients to identify prognostic factors associated with mortality from NOMI.

Overall, there were 541 patients on hemodialysis (HD) and 158 patients on peritoneal dialysis (PD) in our hospital from January 2007 to December 2008. Among these 699 patients, we diagnosed NOMI by surgical and/or radiological criteria. A total of 12 dialysis patients (9 on HD and 3 on PD) developed NOMI during the study period. Result. The incidence of NOMI was 1.04% per patient-year for all dialysis patients (0.95% for HD and 1.35% for PD patients). Most of the 12 patients had chronic hypotension (83.3%, 10/12). Four patients expired following development of NOMI. Our results showed that mortality was significantly higher in patients who were administered a cyclooxygenase (COX) inhibitor prior to ischemia. Hypobicarbonemia during NOMI, which might indicate the severity of hypoperfusion, is also associated with higher mortality. Conclusion. NOMI is rare in dialysis

patients. COX inhibitor administration should be given with caution in long-term hypotensive dialysis Selleck Z-VAD-FMK patients.”
“The tensile modulus of PP/nanoclay/CaCO3 hybrid ternary nanocomposite was analyzed using composite models. Rule of mixtures, inverse rule of mixtures, modified rule of mixtures (MROM), Guth, Paul, Counto, Hirsch, Halpin-Tsai, Takayanagi, and Kerner-Nielsen models were developed for three-phase system containing two nanofillers. Among the studied models, inverse rule of mixtures, Hirsch, Halpin-Tsai, and Kerner-Nielsen models calculated the tensile modulus of PP/nanoclay/CaCO3 ternary nanocomposite successfully compared with others. Furthermore, the Kerner-Nielsen model was simplified to

predict the tensile modulus by volume fractions of nanofillers. Also, Takayanagi model was modified for the current ternary system. The developed Takayanagi model can predict the tensile modulus using Young’s modulus and volume fractions of matrix and nanofillers. (C) 2011 HSP990 in vitro Wiley Periodicals, Inc. J Appl Polym Sci 123: 2309-2319, 2012″
“Cardiovascular (CV) disease is the main cause of death in peritoneal dialysis (PD) patients, and endothelial dysfunction (ED) is an early sign of vascular pathology. Ghrelin, a gastric peptide with CV actions, has been shown to inhibit proatherogenic changes in experimental models. However, another peptide hormone, leptin, may mediate deleterious effects on the CV system. The aim of this study is to evaluate the relationship between plasma ghrelin and leptin levels, and their association with coronary microvascular and endothelial functions in PD patients. Twenty-four (14 females and 10 males; mean age 44 +/- 12 yr) nondiabetic PD patients, between 18 and 70 years of age, were enrolled.